January 2, 2024
Cracking the secrets of virus ‘uncoating’ may help fight infections
Influenza and other viruses pack their genetic material into a protein shell, which must be disassembled for the viruses to efficiently replicate. But how viruses ‘uncoat’ their genes remains largely unknown. Now, FMI researchers have identified crucial features of this uncoating process — work that may inform the development of new antiviral treatments.
Seasonal flu, caused by the influenza A virus, is an acute respiratory infection that can lead to severe illness or death, particularly among the elderly and people with serious medical conditions. Like other viruses, influenza A is a master hijacker that takes control of the machinery of an infected cell to produce new viral particles. The virus’s genetic material is enclosed within a protective protein shell, which must be taken to pieces through a process called uncoating.
Scientists have known that during uncoating, chains of a protein called ubiquitin — which are attached to the surface of the influenza A virus — interact with a cellular enzyme known as HDAC6. HDAC6 in turn binds to components of the cell’s skeleton and to motor proteins, pulling the virus’s protective shell into pieces. However, how viral uncoating works remains unclear.
To investigate this process, Longlong Wang, a postdoctoral fellow in the Matthias group, and his collaborators at the ETH Zurich and the University of Geneva combined lab-based experiments with mathematical modeling. The researchers found that ubiquitin acts as a bridge between HDAC6 and myosin, a key cytoskeletal protein. Actin, another cytoskeletal protein that binds myosin, is also crucial for the opening of the virus’s outer shell. The mathematical modeling also showed that these cytoskeletal proteins can indeed generate the forces required for pulling the virus’s outer shell into pieces.
The findings, published last month in Cell Reports, suggest that preventing the binding of HDAC6 to ubiquitin can help fight infections with influenza A and other viruses. “The interaction between HDAC6 and ubiquitin could be a good therapeutic target,” Wang says.
Next, the researchers plan to investigate ubiquitin’s role in the life cycle of the influenza A virus and how the protein triggers the host’s immune response.
Model of HDAC6-assisted influenza virus uncoating. Image credits: Artcibasova, Wang et al., Cell Reports
Original publication:
Alina Artcibasova*, Longlong Wang*, Stephanie Anchisi, Yohei Yamauchi, Mirco Schmolke, Patrick Matthias^, Jörg Stelling^ A quantitative model for virus uncoating predicts Influenza A infectivity Cell Reports (2023) Advance online publication
*co-first authors
^co-last authors
About the FMI first author
Hailing from Jingzhou, in central China, Longlong Wang got a Master’s degree from the Chinese Academy of Sciences in Shanghai and then joined the FMI in 2014 to pursue a PhD in the Matthias group. After graduating, he stayed in the lab as a postdoctoral fellow to explore the role of ubiquitin in viral infection. In his free time, Longlong enjoys playing basketball and computer games.